212 related articles for article (PubMed ID: 11872234)
41. Killing of Fas ligand-resistant renal carcioma cells by interleukin-2- and BCG-activated effector cells.
Brandau S; Suttmann H; Flad HD; Jocham D; Böhle A
Cancer Immunol Immunother; 2000 Sep; 49(7):369-76. PubMed ID: 10999463
[TBL] [Abstract][Full Text] [Related]
42. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
Gardiner CM; Reen DJ
Immunology; 1998 Apr; 93(4):511-7. PubMed ID: 9659223
[TBL] [Abstract][Full Text] [Related]
43. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
[TBL] [Abstract][Full Text] [Related]
44. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
Gumperz JE; Miyake S; Yamamura T; Brenner MB
J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
[TBL] [Abstract][Full Text] [Related]
45. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
46. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
47. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
48. Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.
Hodgson PD; Grant MD; Michalak TI
Clin Exp Immunol; 1999 Oct; 118(1):63-70. PubMed ID: 10540161
[TBL] [Abstract][Full Text] [Related]
49. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes.
Berthou C; Legros-Maïda S; Soulié A; Wargnier A; Guillet J; Rabian C; Gluckman E; Sasportes M
Blood; 1995 Mar; 85(6):1540-6. PubMed ID: 7534135
[TBL] [Abstract][Full Text] [Related]
50. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of human NK cell-mediated cytotoxicity by exposure to ammonium chloride.
Brander C; Matter-Reissmann UB; Jones NG; Walker BD; Sachs DH; Seebach JD
J Immunol Methods; 2001 Jun; 252(1-2):1-14. PubMed ID: 11334960
[TBL] [Abstract][Full Text] [Related]
52. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
53. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
54. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of cytolytic T cell subsets on intracellular infection.
Stenger S; Mazzaccaro RJ; Uyemura K; Cho S; Barnes PF; Rosat JP; Sette A; Brenner MB; Porcelli SA; Bloom BR; Modlin RL
Science; 1997 Jun; 276(5319):1684-7. PubMed ID: 9180075
[TBL] [Abstract][Full Text] [Related]
56. Regulation of perforin-independent NK cell-mediated cytotoxicity.
Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
[TBL] [Abstract][Full Text] [Related]
57. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.
Screpanti V; Wallin RP; Grandien A; Ljunggren HG
Mol Immunol; 2005 Feb; 42(4):495-9. PubMed ID: 15607805
[TBL] [Abstract][Full Text] [Related]
58. Human T regulatory cells can use the perforin pathway to cause autologous target cell death.
Grossman WJ; Verbsky JW; Barchet W; Colonna M; Atkinson JP; Ley TJ
Immunity; 2004 Oct; 21(4):589-601. PubMed ID: 15485635
[TBL] [Abstract][Full Text] [Related]
59. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
60. Decreased tumor surveillance in perforin-deficient mice.
van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
